All Videos - PainCast

(L) Device Company CEO Panel_ Industry Thoughts from Company Presidents – Video Hero Slider

Device Company CEO Panel: Industry Thoughts from Company Presidents

This panel brings together top executives from leading neuromodulation and minimally invasive spine companies to discuss the current and future state of interventional pain therapies. Each leader shares insights on growth, innovation, compliance, and the need for collaboration across the industry to combat negative public perceptions, regulatory hurdles, and payer resistance. Key themes include expanding patient access, building objective data to validate therapies, elevating compliance standards, and strategically investing in advocacy and education. Panelists emphasize that while competition fuels progress, unity is essential to protect and grow the field for the benefit of patients worldwide.

Watch Now

NEWEST VIDEO

Watch Now

(L) Dr. Corey Hunter – Current Advances in Closed Loop Stimulation – Video Hero Slider

NEWEST VIDEO

Current Advances in Closed Loop Stimulation

Dr. Cory Hunter, President of NANS, presents an in-depth overview of closed-loop spinal cord stimulation (SCS) and the breakthrough potential of ECAP-controlled therapy. He contrasts traditional open-loop systems with real-time, adaptive stimulation that adjusts automatically to patient movement and physiology. Dr. Hunter highlights the EVOKE study’s durable, long-term results and explains how ECAPs may serve as predictive biomarkers, allowing for trial-less implantation and objective pain assessment. He emphasizes the clinical implications for improving outcomes, reducing trial failure, and enhancing patient trust. This presentation signals a new era in neuromodulation and the emerging role of "electroceuticals" in pain medicine.

Watch Now

Watch Now

(L) Device Company CMO Panel_ Guiding Physicians into Working in the Device Industry – Video Hero Slider

NEWEST VIDEOS

This panel brings together Chief Medical Officers (CMOs) from both startups and large medtech companies to discuss their roles, experiences, and advice for physicians considering a similar career path. Each CMO shares insights on transitioning from clinical practice to industry, the importance of advocacy, research, and ROI in decision-making, and how their work now shapes patient care on a broader scale. They emphasize that becoming a CMO requires reputation, leadership, and a deep understanding of medicine, innovation, and business. Their advice is clear: follow your passion, build expertise, and don’t pursue the title—pursue the impact.

Watch Now

Watch Video

Device Company CMO Panel: Guiding Physicians into Working in the Device Industry

(L) Dr. Valimahomed – Does Size Matter In Neuromodulation – Video Hero Slider

NEWEST VIDEO

Does Size Matter In Neuromodulation

This presentation explores the multifaceted role of size in neuromodulation, from electrode spacing and lead configurations to IPG dimensions, waveform characteristics, and energy delivery. Dr. Valimahomed discusses how different lead lengths, spacing, and configurations impact stimulation coverage and efficacy—particularly in spinal cord and peripheral nerve stimulation. He also analyzes how IPG size affects patient comfort, pocket pain, infection risk, and therapy adoption. Future-forward technologies like injectable and bioresorbable systems, AI-based programming, and neural dose optimization offer promising paths to miniaturization and precision. Ultimately, size matters—but contextually, depending on anatomical targets, clinical goals, and device trade-offs.

Watch Now

Watch Now

(L) Dr. Leonardo Kapural – Neuromodulation for Peripheral Neuropathy vs Mononeuropathy – Video Hero Slider

Watch Now

NEWEST VIDEO

Watch Now

Neuromodulation for Peripheral Neuropathy vs Mononeuropathy

In this insightful lecture, Dr. Leonardo Kapural reflects on 13 years of contributions to the Mediterranean Pain Forum and presents cutting-edge advancements in neuromodulation. Highlighting data from multiple studies, including magnetic and high-frequency peripheral nerve stimulation, the talk explores non-invasive alternatives to medication for neuropathic and diabetic pain, mononeuropathy, and post-amputation pain. With comparisons to traditional drugs like gabapentin, the speaker emphasizes the greater efficacy and patient satisfaction of neuromodulation. He also traces the evolution of techniques from invasive surgical placements to modern ultrasound-guided approaches and compact external stimulators, calling for earlier adoption of neuromodulation in pain treatment algorithms.

Slide

This panel brings together top executives from leading neuromodulation and minimally invasive spine companies to discuss the current and future state of interventional pain therapies. Each leader shares insights on growth, innovation, compliance, and the need for collaboration across the industry to combat negative public perceptions, regulatory hurdles, and payer resistance. Key themes include expanding patient access, building objective data to validate therapies, elevating compliance standards, and strategically investing in advocacy and education. Panelists emphasize that while competition fuels progress, unity is essential to protect and grow the field for the benefit of patients worldwide.

Device Company CEO Panel: Industry Thoughts from Company Presidents

Slide

Dr. Cory Hunter, President of NANS, presents an in-depth overview of closed-loop spinal cord stimulation (SCS) and the breakthrough potential of ECAP-controlled therapy. He contrasts traditional open-loop systems with real-time, adaptive stimulation that adjusts automatically to patient movement and physiology. Dr. Hunter highlights the EVOKE study’s durable, long-term results and explains how ECAPs may serve as predictive biomarkers, allowing for trial-less implantation and objective pain assessment. He emphasizes the clinical implications for improving outcomes, reducing trial failure, and enhancing patient trust. This presentation signals a new era in neuromodulation and the emerging role of "electroceuticals" in pain medicine.

Current Advances in Closed Loop Stimulation

Slide

Device Company CMO Panel: Guiding Physicians into Working in the Device Industry

This panel brings together Chief Medical Officers (CMOs) from both startups and large medtech companies to discuss their roles, experiences, and advice for physicians considering a similar career path. Each CMO shares insights on transitioning from clinical practice to industry, the importance of advocacy, research, and ROI in decision-making, and how their work now shapes patient care on a broader scale. They emphasize that becoming a CMO requires reputation, leadership, and a deep understanding of medicine, innovation, and business. Their advice is clear: follow your passion, build expertise, and don’t pursue the title—pursue the impact.

Slide

This presentation explores the multifaceted role of size in neuromodulation, from electrode spacing and lead configurations to IPG dimensions, waveform characteristics, and energy delivery. Dr. Valimahomed discusses how different lead lengths, spacing, and configurations impact stimulation coverage and efficacy—particularly in spinal cord and peripheral nerve stimulation. He also analyzes how IPG size affects patient comfort, pocket pain, infection risk, and therapy adoption. Future-forward technologies like injectable and bioresorbable systems, AI-based programming, and neural dose optimization offer promising paths to miniaturization and precision. Ultimately, size matters—but contextually, depending on anatomical targets, clinical goals, and device trade-offs.

Does Size Matter In Neuromodulation

Slide

In this insightful lecture, Dr. Leonardo Kapural reflects on 13 years of contributions to the Mediterranean Pain Forum and presents cutting-edge advancements in neuromodulation. Highlighting data from multiple studies, including magnetic and high-frequency peripheral nerve stimulation, the talk explores non-invasive alternatives to medication for neuropathic and diabetic pain, mononeuropathy, and post-amputation pain. With comparisons to traditional drugs like gabapentin, the speaker emphasizes the greater efficacy and patient satisfaction of neuromodulation. He also traces the evolution of techniques from invasive surgical placements to modern ultrasound-guided approaches and compact external stimulators, calling for earlier adoption of neuromodulation in pain treatment algorithms.

Neuromodulation for Peripheral Neuropathy vs Mononeuropathy

Recent Popular

4 Results found

Videos

Pro

November 17, 2021

Lam – US assisted intraosseous injection of biologics for bone marrow edema

Dr. Stanley Lam discusses ultrasound assisted intraosseous injection of biologics for bone marrow edema. Osteoarthritis remains a problem, but regenerative medicine may be a viable treatment option. Intraosseous injections are discussed, including of platelet...

$3.75

Pro

Aaron Kenneth Calodney

November 17, 2021

Calodney – Biologic/regenerative medicine: PRP and Bone Marrow

Dr. Aaron Calodney discusses the evolution, physiology, acquisition, preparation, and technical considerations of using platelet-rich plasma (PRP) and bone marrow in clinical pain practice. He first discusses the basics of regenerative medicine. PRP is,...

$3.75

Pro

George Chang Chien

November 17, 2021

Chang Chien – Regenerative Approach for the Hip and Knee

Dr. George C. Chang Chien describes the common hip and knee conditions that can be treated by regenerative medicine procedures, as well as the diagnostic approaches used. He discusses the anatomy of the hip...

$3.75

Pro

Douglas P. Beall

November 17, 2021

Beall – Intradiscal Stem Cell Therapy

Dr. Doug Beall describes the state of intradiscal stem cell therapy, specifically for regenerating degenerative discs. Discogenic low back pain is a huge problem, particularly among younger people. But low back pain can be...

$3.75